Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Breast Neoplasms"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Breast+Neoplasms%22&lookfor=%22ClinicalTrials.gov%22&type=JournalTitle&page=5
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Breast+Neoplasms%22&lookfor=%22ClinicalTrials.gov%22&type=JournalTitle&page=5
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Breast+Neoplasms%22&lookfor=%22ClinicalTrials.gov%22&type=JournalTitle&page=5
PubPharm (10.270)
41
Hypofractionated LocoRegional Radiotherapy in Breast Cancer : Randomized Trial of Hypofractionated LocoRegional Radiotherapy in Breast Cancer and Lymphedema (RHEAL)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
42
BreastVAX: Radiation Boost to Enhance Immune Checkpoint Blockade Therapy : Preoperative Use of Radiation Boost to Enhance Effectiveness of Immune Checkpoint Blockade Therapy in Operable Breast Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
43
A Study of PF-07260437 in Advanced or Metastatic Solid Tumors : A PHASE 1 DOSE ESCALATION AND EXPANSION STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETIC, PHARMACODYNAMIC, AND ANTITUMOR ACTIVITY OF PF-07260437 IN ADVANCED OR METASTATIC SOLID TUMORS
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
44
Study of Abemaciclib and Elacestrant in Patients With Brain Metastasis Due to HR+/HER2- Breast Cancer : An Open-label Multicenter Phase 1b-2 Study of Elacestrant in Combination With Abemaciclib in Women and Men With Brain Metastasis From Estrogen Receptor Positive, HER-2 Negative Breast Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
45
Adjuvant Monotherapy With Endocrine Therapy or Accelerated Partial Breast Irradiation Following Lumpectomy for Low Risk Breast Cancer Patients Over 65 (CAMERAN) : Comparison of Adjuvant Monotherapy With Endocrine Therapy or Accelerated Partial Breast Irradiation Following Lumpectomy for Low Risk Breast Cancer Patients Over 65 (CAMERAN)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
46
Testing the Use of Fulvestrant and Binimetinib Targeted Treatment for NF1 Mutation in Hormone Receptor-Positive Metastatic Breast Cancer (A ComboMATCH Treatment Trial) : Phase 2 Trial of Fulvestrant and Binimetinib in Patients With Hormone Receptor-Positive Metastatic Breast Cancer With Inactivating or Inferred Inactivating NF1 Alterations: A ComboMATCH Treatment Trial
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
47
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial : Molecular Analysis for Combination Therapy Choice (ComboMATCH)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
48
A Study to Learn More About How Well Elinzanetant Works and How Safe it is Compared to Placebo for the Treatment of Hot Flashes Caused by Anti-cancer Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer : A Double-blind, Randomized, Placebo-controlled Multicenter Study to Investigate Efficacy and Safety of Elinzanetant for the Treatment of Vasomotor Symptoms Induced by Adjuvant Endocrine Therapy, Over 52 Weeks and Optionally for Additional 2 Years in Women With Hormone-receptor Positive Breast Cancer:
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
49
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation : An Open Label, Randomized, Multicenter Study Comparing the Efficacy and Safety of the Combination of Lasofoxifene and Abemaciclib to the Combination of Fulvestrant and Abemaciclib for the Treatment of Pre- and Postmenopausal Women and Men With Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
50
[177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer : A Phase Ib Dose Finding Study Assessing Safety and Activity of [177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With Estrogen Receptor Positive, Human Epidermal Growth Factor Receptor-2 Negative and Gastrin Releasing Peptide Receptor Positive Advanced Breast Cancer Experiencing Early Relapse From (Neo)Adjuvant Endocrine Therapy or Who Have Progressed on Endocrine Therapy in Combination With a CDK4/6 Inhibitor for Advanced Disease
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
[1]
« Vorheriger
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[1027]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Breast Neoplasms
Medienart
10.270
Aufsätze
10.270
E-Artikel
10.270
E-Ressourcen
Zeitschriftentitel
10.270
ClinicalTrials.gov
Thema
Breast Neoplasms
10.269
610
8.085
Study Type: Interventional
4.195
Recruitment Status: Completed
2.500
Medical Condition: Breast Cancer
2.491
Phase: Phase 2
2.352
Recruitment Status: Recruiting
2.104
Study Type: Observational
1.129
Recruitment Status: Active, not recruiting
950
Phase: Phase 3
916
Phase: Phase 1
826
Recruitment Status: Terminated
757
Triple Negative Breast Neoplasms
674
Recruitment Status: Unknown status
623
Recruitment Status: Not yet recruiting
524
Carcinoma
401
Neoplasms
345
Medical Condition: Metastatic Breast Cancer
341
Recruitment Status: Withdrawn
297
Phase: Phase 1, Phase 2
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
6.472
2020-
3.626
2010-2019
172
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
10.270
Englisch
Haven't found what you're looking for?
Wird geladen...